UP!
| Period | Date | Adjusted Actuals EPS | GAAP EPS |
|---|---|---|---|
| Q3 2022 | 2022-11-10 | Future report Set alerts | |
| Q2 2022 | 2022-08-11 | -0.08 | -0.08 |
| Q1 2022 | 2022-05-12 | 0.00 | 0.00 |
| Q4 2021 | 2022-02-16 | 0.00 | 0.00 |
| Q3 2021 | 2021-11-12 | -0.07 | -0.07 |
| Q2 2021 | 2021-08-12 | 0.00 | 0.00 |
| Q1 2021 | 2021-05-13 | 0.00 | 0.00 |
| Q4 2020 | 2021-02-18 | 0.00 | 0.00 |
| Q3 2020 | 2020-10-26 | -0.08 | -0.08 |
| Q2 2020 | 2020-07-28 | -0.10 | -0.10 |
| 7067-03-31 | ||||
| 2766-03-21 | ||||
| 2013-01-04 | Reiterated | Ladenburg Thalmann | Buy | $10.50 to $6 |
| 2012-05-24 | Downgrade | MLV & Co | Buy to Hold | |
| 2011-10-18 | Reiterated | MLV Capital | Buy | $13 to $6 |
| 2011-06-22 | Initiated | Global Hunter Securities | Buy | $4 |
| 2010-05-12 | Initiated | Wedbush | Outperform | $13 |
| 2008-11-12 | Reiterated | Ladenburg Thalmann | Buy | $22 to $6 |
| 2008-05-15 | Initiated | Rodman & Renshaw | Mkt Outperform | $9 |
| 2007-07-09 | Initiated | Punk, Ziegel & Co | Buy | $22 |
| 1970-01-01 |
| 7067-03-31 | ||||
| 2766-03-21 | ||||
| 2013-01-04 | Reiterated | Ladenburg Thalmann | Buy | $10.50 to $6 |
| 2012-05-24 | Downgrade | MLV & Co | Buy to Hold | |
| 2011-10-18 | Reiterated | MLV Capital | Buy | $13 to $6 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In MNOV 32 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|---|
| Vanguard Group, Inc | 1.83M |
| BlackRock Fund Advisors | 1.42M |
| Essex Woodlands Health Ventures, Inc. | 1.11M |
| BlackRock Inc. | 0.71M |
| CITIGROUP INC | 0.45M |
| GEODE CAPITAL MANAGEMENT, LLC | 0.43M |
| BlackRock Institutional Trust Company, N.A. | 0.42M |
| JPMORGAN CHASE & CO | 0.30M |
| BRIDGEWAY CAPITAL MANAGEMENT INC | 0.20M |
| UBS Group AG | 0.18M |
| NORTHERN TRUST CORP | 0.16M |
| BARCLAYS PLC | 0.16M |
| BANK OF AMERICA CORP /DE/ | 0.15M |
| RENAISSANCE TECHNOLOGIES LLC | 0.15M |
| STATE STREET CORP | 0.14M |
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| IWAKI YUICHI Chief Executive Officer | 3.07% (740594) | MNOV / |
| Izumi Tatsuo | 2.48% (600000) | MNOV / |
| Okajima Masatsune VP and Head of Japanese Office | 0.45% (108941) | MNOV / |
| Matsuda Kazuko Chief Medical Officer | 0.26% (62003) | MNOV / |
| Shigeta Hiroaki | 0.19% (45000) | MDCO / MNOV / |
| Kalafer Michael E Chief Medical Officer | 0.13% (31744) | MNOV / |
| Kobayashi Yutaka | 0.10% (25000) | MNOV / |
| Ishizaka Yoshio | 0.04% (10000) | MNOV / |
| OBrien Geoffrey Vice President | 0.03% (8300) | MNOV / |
| O'Toole David D | 0.02% (5000) | CAPN / CDXS / MNOV / RGDX / |
| COFFEE MICHAEL DENIS Chief Business Officer | 0.02% (4000) | MNOV / |
| Johnson Kirk William Chief Scientific Officer | 0.01% (1700) | MNOV / |
UM